• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Studio
  • Genomics
  • Solutions
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • Newsroom
    • Careers
Get started
Sign in
Understanding the impact of the COVID-19 pandemic on childhood MMR vaccination patterns

Understanding the impact of the COVID-19 pandemic on childhood MMR vaccination patterns

by Truveta Research | Jun 11, 2025 | Research, Research Insights

Timely receipt of the MMR vaccine for children has been declining since 2021, with just 76.9% of children receiving the MMR vaccine in 2024 on time.  The odds of non-vaccination by age two for measles were higher among male children, children in rural areas, White...
Evaluating recent trends in early measles vaccinations in Texas

Evaluating recent trends in early measles vaccinations in Texas

by Truveta Research | May 16, 2025 | Research, Research Insights

Among children in Texas receiving a first measles vaccine prior to two years of life: In March and April 2025, 20.1% of all first measles vaccines were administered to children early (6-11 months). This is 11.5-fold higher than in 2019, when there were international...
Latest trends in two-dose vaccination against measles among children in the US

Latest trends in two-dose vaccination against measles among children in the US

by Truveta Research | Apr 3, 2025 | Research, Research Insights

The vaccination rate by age six fluctuated between 2018 and 2021; however, rates have decreased since 2021. The rate in 2021 was 81.9% compared to 80.4% in 2024. This means for every 70 children, roughly one more child received two measles vaccines in 2021 compared to...
Latest US first-time measles vaccination trends for children under 24 months

Latest US first-time measles vaccination trends for children under 24 months

by Truveta Research | Apr 3, 2025 | Research, Research Insights

Measles vaccination rates for children under 24 months in 2024 remain lower than in 2020.   In 2024, the average yearly measles vaccination rate for children by 13 months was 58.9% and 68.5% for children by 15 months.   Vaccination patterns for children living in both...

Share this


Recent posts

  • Real-world survival outcomes for CRT and CCM therapies align with landmark trials
  • Understanding the potential impact of the upcoming ACIP vote on thimerosal-containing influenza vaccines
  • Biosimilar use is on the rise – but 1 in 8 patients return to Humira

Follow Truveta


Sign up for our newsletter

Ready to accelerate your research with representative, complete, and timely real-world data?

Truveta Data

Truveta Genome Project

Solutions

Research

Resources

Blog

Newsroom

Careers

Privacy notice

Contact us

© Truveta 2025

Our website uses cookies to ensure you have the best experience.AcceptPrivacy notice